Is it Safe to Invest in Google With OpenAI Threats?
For the last 20 years, Google parent company Alphabet (NASDAQ:GOOG,…
Sell
25
PRGO Quote, Financials, Valuation and Earnings
Last price:
$26.37
Seasonality move
:
0.51%
Day range:
$24.60 - $25.16
52-week range:
$23.14 - $33.35
Dividend yield:
4.53%
P/E ratio:
--
P/S ratio:
0.78x
P/B ratio:
0.78x
Volume:
2.3M
Avg. volume:
1.4M
1-year change:
-26.17%
Market cap:
$3.4B
Revenue:
$4.4B
EPS (TTM):
-$1.25
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
PRGO
Perrigo Co PLC
|
$1.1B | $0.57 | 0.84% | 5382.8% | $34.60 |
|
ALKS
Alkermes PLC
|
$304.1M | $0.24 | -14.09% | -21.11% | $39.57 |
|
AMRN
Amarin Corp PLC
|
$50.7M | -$0.40 | -28.71% | -- | $13.50 |
|
AVDL
Avadel Pharmaceuticals PLC
|
$50.6M | -$0.07 | 86.06% | -84.44% | $17.50 |
|
JAZZ
Jazz Pharmaceuticals PLC
|
$983.8M | $4.66 | 9.16% | 309.21% | $190.28 |
|
MDT
Medtronic PLC
|
$8.8B | $1.58 | 2.59% | 221.68% | $97.10 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
PRGO
Perrigo Co PLC
|
$24.68 | $34.60 | $3.4B | -- | $0.29 | 4.53% | 0.78x |
|
ALKS
Alkermes PLC
|
$30.36 | $39.57 | $5B | 14.53x | $0.00 | 0% | 3.37x |
|
AMRN
Amarin Corp PLC
|
$10.19 | $13.50 | $211M | -- | $0.00 | 0% | 0.92x |
|
AVDL
Avadel Pharmaceuticals PLC
|
$8.64 | $17.50 | $834.9M | -- | $0.00 | 0% | 4.86x |
|
JAZZ
Jazz Pharmaceuticals PLC
|
$111.17 | $190.28 | $6.8B | 12.65x | $0.00 | 0% | 1.75x |
|
MDT
Medtronic PLC
|
$82.32 | $97.10 | $105.6B | 25.02x | $0.70 | 3.4% | 3.22x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
PRGO
Perrigo Co PLC
|
45.58% | 0.039 | 103.15% | 1.15x |
|
ALKS
Alkermes PLC
|
-- | 1.013 | -- | 2.72x |
|
AMRN
Amarin Corp PLC
|
-- | 0.064 | -- | 2.31x |
|
AVDL
Avadel Pharmaceuticals PLC
|
-- | -2.648 | -- | 2.21x |
|
JAZZ
Jazz Pharmaceuticals PLC
|
59.88% | 0.854 | 81.81% | 3.57x |
|
MDT
Medtronic PLC
|
34.97% | 0.573 | 22.74% | 1.19x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
PRGO
Perrigo Co PLC
|
$385.9M | $164.8M | -1.98% | -3.76% | 9.94% | $274.9M |
|
ALKS
Alkermes PLC
|
$257.3M | $13.8M | 22.98% | 25.91% | 8.32% | $88.7M |
|
AMRN
Amarin Corp PLC
|
-$9.6M | -$52.5M | -15.41% | -15.41% | -60.86% | -$13.3M |
|
AVDL
Avadel Pharmaceuticals PLC
|
$45.6M | -$3.3M | -63.43% | -63.43% | -4.49% | $7.9M |
|
JAZZ
Jazz Pharmaceuticals PLC
|
$959.5M | $190.8M | 5.74% | 14.39% | 16.95% | $385.3M |
|
MDT
Medtronic PLC
|
$5.5B | $1.7B | 5.58% | 8.56% | 20.73% | $2.1B |
Perrigo Co PLC vs. Competitors
-
Which has Higher Returns PRGO or ALKS?
Alkermes PLC has a net margin of -3.91% compared to Perrigo Co PLC's net margin of 7.33%. Perrigo Co PLC's return on equity of -3.76% beat Alkermes PLC's return on equity of 25.91%.
Company Gross Margin Earnings Per Share Invested Capital PRGOPerrigo Co PLC33.9% -$0.32 $7.9B ALKSAlkermes PLC83.95% $0.13 $1.5B -
What do Analysts Say About PRGO or ALKS?
Perrigo Co PLC has a consensus price target of $34.60, signalling upside risk potential of 40.2%. On the other hand Alkermes PLC has an analysts' consensus of $39.57 which suggests that it could grow by 30.34%. Given that Perrigo Co PLC has higher upside potential than Alkermes PLC, analysts believe Perrigo Co PLC is more attractive than Alkermes PLC.
Company Buy Ratings Hold Ratings Sell Ratings PRGOPerrigo Co PLC1 3 0 ALKSAlkermes PLC8 6 0 -
Is PRGO or ALKS More Risky?
Perrigo Co PLC has a beta of 0.448, which suggesting that the stock is 55.199% less volatile than S&P 500. In comparison Alkermes PLC has a beta of 0.512, suggesting its less volatile than the S&P 500 by 48.82%.
-
Which is a Better Dividend Stock PRGO or ALKS?
Perrigo Co PLC has a quarterly dividend of $0.29 per share corresponding to a yield of 4.53%. Alkermes PLC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Perrigo Co PLC pays -88.77% of its earnings as a dividend. Alkermes PLC pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PRGO or ALKS?
Perrigo Co PLC quarterly revenues are $1.1B, which are larger than Alkermes PLC quarterly revenues of $306.5M. Perrigo Co PLC's net income of -$44.5M is lower than Alkermes PLC's net income of $22.5M. Notably, Perrigo Co PLC's price-to-earnings ratio is -- while Alkermes PLC's PE ratio is 14.53x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Perrigo Co PLC is 0.78x versus 3.37x for Alkermes PLC. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PRGOPerrigo Co PLC0.78x -- $1.1B -$44.5M ALKSAlkermes PLC3.37x 14.53x $306.5M $22.5M
-
Which has Higher Returns PRGO or AMRN?
Amarin Corp PLC has a net margin of -3.91% compared to Perrigo Co PLC's net margin of -78.03%. Perrigo Co PLC's return on equity of -3.76% beat Amarin Corp PLC's return on equity of -15.41%.
Company Gross Margin Earnings Per Share Invested Capital PRGOPerrigo Co PLC33.9% -$0.32 $7.9B AMRNAmarin Corp PLC-15.36% -$0.12 $486.2M -
What do Analysts Say About PRGO or AMRN?
Perrigo Co PLC has a consensus price target of $34.60, signalling upside risk potential of 40.2%. On the other hand Amarin Corp PLC has an analysts' consensus of $13.50 which suggests that it could grow by 32.48%. Given that Perrigo Co PLC has higher upside potential than Amarin Corp PLC, analysts believe Perrigo Co PLC is more attractive than Amarin Corp PLC.
Company Buy Ratings Hold Ratings Sell Ratings PRGOPerrigo Co PLC1 3 0 AMRNAmarin Corp PLC0 1 0 -
Is PRGO or AMRN More Risky?
Perrigo Co PLC has a beta of 0.448, which suggesting that the stock is 55.199% less volatile than S&P 500. In comparison Amarin Corp PLC has a beta of 0.660, suggesting its less volatile than the S&P 500 by 33.97%.
-
Which is a Better Dividend Stock PRGO or AMRN?
Perrigo Co PLC has a quarterly dividend of $0.29 per share corresponding to a yield of 4.53%. Amarin Corp PLC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Perrigo Co PLC pays -88.77% of its earnings as a dividend. Amarin Corp PLC pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PRGO or AMRN?
Perrigo Co PLC quarterly revenues are $1.1B, which are larger than Amarin Corp PLC quarterly revenues of $62.3M. Perrigo Co PLC's net income of -$44.5M is higher than Amarin Corp PLC's net income of -$48.6M. Notably, Perrigo Co PLC's price-to-earnings ratio is -- while Amarin Corp PLC's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Perrigo Co PLC is 0.78x versus 0.92x for Amarin Corp PLC. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PRGOPerrigo Co PLC0.78x -- $1.1B -$44.5M AMRNAmarin Corp PLC0.92x -- $62.3M -$48.6M
-
Which has Higher Returns PRGO or AVDL?
Avadel Pharmaceuticals PLC has a net margin of -3.91% compared to Perrigo Co PLC's net margin of -10%. Perrigo Co PLC's return on equity of -3.76% beat Avadel Pharmaceuticals PLC's return on equity of -63.43%.
Company Gross Margin Earnings Per Share Invested Capital PRGOPerrigo Co PLC33.9% -$0.32 $7.9B AVDLAvadel Pharmaceuticals PLC90.45% -$0.05 $73.8M -
What do Analysts Say About PRGO or AVDL?
Perrigo Co PLC has a consensus price target of $34.60, signalling upside risk potential of 40.2%. On the other hand Avadel Pharmaceuticals PLC has an analysts' consensus of $17.50 which suggests that it could grow by 102.55%. Given that Avadel Pharmaceuticals PLC has higher upside potential than Perrigo Co PLC, analysts believe Avadel Pharmaceuticals PLC is more attractive than Perrigo Co PLC.
Company Buy Ratings Hold Ratings Sell Ratings PRGOPerrigo Co PLC1 3 0 AVDLAvadel Pharmaceuticals PLC7 0 0 -
Is PRGO or AVDL More Risky?
Perrigo Co PLC has a beta of 0.448, which suggesting that the stock is 55.199% less volatile than S&P 500. In comparison Avadel Pharmaceuticals PLC has a beta of 1.397, suggesting its more volatile than the S&P 500 by 39.743%.
-
Which is a Better Dividend Stock PRGO or AVDL?
Perrigo Co PLC has a quarterly dividend of $0.29 per share corresponding to a yield of 4.53%. Avadel Pharmaceuticals PLC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Perrigo Co PLC pays -88.77% of its earnings as a dividend. Avadel Pharmaceuticals PLC pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PRGO or AVDL?
Perrigo Co PLC quarterly revenues are $1.1B, which are larger than Avadel Pharmaceuticals PLC quarterly revenues of $50.4M. Perrigo Co PLC's net income of -$44.5M is lower than Avadel Pharmaceuticals PLC's net income of -$5M. Notably, Perrigo Co PLC's price-to-earnings ratio is -- while Avadel Pharmaceuticals PLC's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Perrigo Co PLC is 0.78x versus 4.86x for Avadel Pharmaceuticals PLC. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PRGOPerrigo Co PLC0.78x -- $1.1B -$44.5M AVDLAvadel Pharmaceuticals PLC4.86x -- $50.4M -$5M
-
Which has Higher Returns PRGO or JAZZ?
Jazz Pharmaceuticals PLC has a net margin of -3.91% compared to Perrigo Co PLC's net margin of 17.56%. Perrigo Co PLC's return on equity of -3.76% beat Jazz Pharmaceuticals PLC's return on equity of 14.39%.
Company Gross Margin Earnings Per Share Invested Capital PRGOPerrigo Co PLC33.9% -$0.32 $7.9B JAZZJazz Pharmaceuticals PLC88.17% $3.11 $10.2B -
What do Analysts Say About PRGO or JAZZ?
Perrigo Co PLC has a consensus price target of $34.60, signalling upside risk potential of 40.2%. On the other hand Jazz Pharmaceuticals PLC has an analysts' consensus of $190.28 which suggests that it could grow by 71.16%. Given that Jazz Pharmaceuticals PLC has higher upside potential than Perrigo Co PLC, analysts believe Jazz Pharmaceuticals PLC is more attractive than Perrigo Co PLC.
Company Buy Ratings Hold Ratings Sell Ratings PRGOPerrigo Co PLC1 3 0 JAZZJazz Pharmaceuticals PLC9 2 0 -
Is PRGO or JAZZ More Risky?
Perrigo Co PLC has a beta of 0.448, which suggesting that the stock is 55.199% less volatile than S&P 500. In comparison Jazz Pharmaceuticals PLC has a beta of 0.382, suggesting its less volatile than the S&P 500 by 61.836%.
-
Which is a Better Dividend Stock PRGO or JAZZ?
Perrigo Co PLC has a quarterly dividend of $0.29 per share corresponding to a yield of 4.53%. Jazz Pharmaceuticals PLC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Perrigo Co PLC pays -88.77% of its earnings as a dividend. Jazz Pharmaceuticals PLC pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PRGO or JAZZ?
Perrigo Co PLC quarterly revenues are $1.1B, which are larger than Jazz Pharmaceuticals PLC quarterly revenues of $1.1B. Perrigo Co PLC's net income of -$44.5M is lower than Jazz Pharmaceuticals PLC's net income of $191.1M. Notably, Perrigo Co PLC's price-to-earnings ratio is -- while Jazz Pharmaceuticals PLC's PE ratio is 12.65x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Perrigo Co PLC is 0.78x versus 1.75x for Jazz Pharmaceuticals PLC. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PRGOPerrigo Co PLC0.78x -- $1.1B -$44.5M JAZZJazz Pharmaceuticals PLC1.75x 12.65x $1.1B $191.1M
-
Which has Higher Returns PRGO or MDT?
Medtronic PLC has a net margin of -3.91% compared to Perrigo Co PLC's net margin of 15.61%. Perrigo Co PLC's return on equity of -3.76% beat Medtronic PLC's return on equity of 8.56%.
Company Gross Margin Earnings Per Share Invested Capital PRGOPerrigo Co PLC33.9% -$0.32 $7.9B MDTMedtronic PLC66.49% $1.01 $76.2B -
What do Analysts Say About PRGO or MDT?
Perrigo Co PLC has a consensus price target of $34.60, signalling upside risk potential of 40.2%. On the other hand Medtronic PLC has an analysts' consensus of $97.10 which suggests that it could grow by 17.95%. Given that Perrigo Co PLC has higher upside potential than Medtronic PLC, analysts believe Perrigo Co PLC is more attractive than Medtronic PLC.
Company Buy Ratings Hold Ratings Sell Ratings PRGOPerrigo Co PLC1 3 0 MDTMedtronic PLC12 13 1 -
Is PRGO or MDT More Risky?
Perrigo Co PLC has a beta of 0.448, which suggesting that the stock is 55.199% less volatile than S&P 500. In comparison Medtronic PLC has a beta of 0.811, suggesting its less volatile than the S&P 500 by 18.855%.
-
Which is a Better Dividend Stock PRGO or MDT?
Perrigo Co PLC has a quarterly dividend of $0.29 per share corresponding to a yield of 4.53%. Medtronic PLC offers a yield of 3.4% to investors and pays a quarterly dividend of $0.70 per share. Perrigo Co PLC pays -88.77% of its earnings as a dividend. Medtronic PLC pays out 99.73% of its earnings as a dividend. Medtronic PLC's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios PRGO or MDT?
Perrigo Co PLC quarterly revenues are $1.1B, which are smaller than Medtronic PLC quarterly revenues of $8.3B. Perrigo Co PLC's net income of -$44.5M is lower than Medtronic PLC's net income of $1.3B. Notably, Perrigo Co PLC's price-to-earnings ratio is -- while Medtronic PLC's PE ratio is 25.02x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Perrigo Co PLC is 0.78x versus 3.22x for Medtronic PLC. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PRGOPerrigo Co PLC0.78x -- $1.1B -$44.5M MDTMedtronic PLC3.22x 25.02x $8.3B $1.3B
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Broadcom Stock a Millionaire Maker?
Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…
Is Berkshire The Best Stock to Buy in a Bad Market?
Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
60
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 7
Regencell Bioscience Holdings [RGC] is up 25.83% over the past day.
Buy
77
FARO alert for May 7
Faro Technologies [FARO] is down 0.19% over the past day.
Buy
53
SRPT alert for May 7
Sarepta Therapeutics [SRPT] is down 19.59% over the past day.
